Zavis Editorial

Zavis Intelligence Team

Editorial Desk

Biography

The Zavis Intelligence Team byline is used for news data briefs from the Zavis Intelligence Desk. Each brief reports a story first published by another outlet, which it names and links, and adds Zavis data that gives the story context. Briefs are drafted by AI and published only after automated checks confirm that every number comes from the Zavis data or the original report.

Published coverage

Regulatory & Policy

UAE has 15 registered GLP-1 studies on record, but only 1 is recruiting or active now

Across the GCC, the Zavis GLP-1 and Peptides Monitor counts 35 registered studies of GLP-1 and related medicines, with 10 recruiting or active now.

30 Oct 2026 · 4 min read

UAE has 15 registered GLP-1 studies on record, but only 1 is recruiting or active now

Market IntelligenceBreaking

Just 1 of 15 UAE-site GLP-1 studies is recruiting or active, Zavis data shows

Saudi Arabia also has 15 studies on record and 5 recruiting or active. The US FDA lists 9 GLP-1 presentations as current shortages.

27 Oct 2026 · 6 min read

Just 1 of 15 UAE-site GLP-1 studies is recruiting or active, Zavis data shows

Finance & InvestmentBreaking

Eli Lilly sponsors the one GLP-1 study active at a UAE site, out of 15 registered

Saudi Arabia also has 15 registered GLP-1 studies on record, and 5 of them are recruiting or active now. Kuwait has 4, according to the Zavis GLP-1 and Peptides Monitor.

21 Oct 2026 · 5 min read

Eli Lilly sponsors the one GLP-1 study active at a UAE site, out of 15 registered

Health Tech & Innovation

UAE has 175 clinical studies recruiting or active, Zavis monitor shows

Industry sponsors 46.9% of active UAE studies, and 34 include phase 3, according to the Zavis GCC Clinical Trials Monitor.

20 Oct 2026 · 4 min read

UAE has 175 clinical studies recruiting or active, Zavis monitor shows